“

Gene Pool is live. The bet: the genetics revolution. CRISPR is FDA-approved and most of the field is still beaten down from the 2021 winter. Anchored by the names already shipping (Vertex made the first approved CRISPR drug), plus Intellia on in-vivo editing, RNA medicine, next-gen metabolic, and genomics toolmakers (Twist, Natera, Tempus). Many small positions because biology is binary: most trials fail, the basket survives. Holding the readouts, not trading them.

”